Plaintiff Carissa Sullivan, who has cerebral palsy and spastic quadriplegia, claims that the SynchroMed II infusion pump she had implanted in 2011 failed in 2015, causing injuries from withdrawal of the drug baclofen. Baclofen is used to control spasticity. Sullivan claims she needed pump replacement surgery.
IN CASE YOU MISSED IT
- Canada approves Tandem Diabetes Caree’s advanced hybrid closed-loop insulin pump
- Appeals court nixes GSK’s petition for new trial in Vectura patent spat
- Lilly and Ypsomed team up on automated insulin delivery
- Key steps for medical device manufacturers effective CAPA management
- Alaris remediation could cost BD up to $244M